Letters19 September 2006Symptomatic Myopathy due to Red Yeast RicePaul S. Mueller, MDPaul S. Mueller, MDFrom the Mayo Clinic, Rochester, Minnesota.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-145-6-200609190-00021 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Red yeast rice is a dietary supplement that contains 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors and is used for self-treatment of hyperlipidemia.Objective: To report a case of symptomatic myopathy associated with use of red yeast rice.Case Report: In January 2005, a 61-year-old woman presented for a general health assessment. She reported a history of hyperlipidemia but had no symptoms at rest or with activities. Her medications included an estradiol transdermal patch (0.05 mg/wk), aspirin (81 mg/d), and a multivitamin (once daily). Her vital signs were normal, weight was 70.9 kg, and body mass index was 29.2 kg/m2. ...References1. Thompson Coon JS, Ernst E. Herbs for serum cholesterol reduction: a systematic view. J Fam Pract. 2003;52:468-78. [PMID: 12791229] MedlineGoogle Scholar2. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999;69:231-6. [PMID: 9989685] CrossrefMedlineGoogle Scholar3. Prasad GV, Wong T, Meliton G, Bhaloo S. Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation. 2002;74:1200-1. [PMID: 12438974] CrossrefMedlineGoogle Scholar4. Smith DJ, Olive KE. Chinese red rice-induced myopathy. South Med J. 2003;96:1265-7. [PMID: 14696880] CrossrefMedlineGoogle Scholar5. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569-75. [PMID: 9820257] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Paul S. Mueller, MDAffiliations: From the Mayo Clinic, Rochester, Minnesota.Acknowledgment: Editing, proofreading, and reference verification were provided by the Section of Scientific Publications, Mayo Clinic.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoSymptomatic Hepatitis Associated with the Use of Herbal Red Yeast Rice Harry Roselle , Andrew Ekatan , Jausheng Tzeng , Mark Sapienza , and Jeffrey Kocher Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients Anna L. Kolpakchi , Ikedieze I. Chukwu , and Maria T. Vlachaki Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients David G. Le Couteur Metrics Cited byThe Role of Nutraceutical Supplements, Monacolin K and Astaxanthin, and Diet in Blood Cholesterol Homeostasis in Patients with MyopathyPhysical Activity and Exercise for Older AdultsDecreased Risk of Stroke in People Using Red Yeast Rice Prescriptions (LipoCol Forte®): a Total Population-Based Retrospective Cohort StudyAdverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting SystemsScientific opinion on the safety of monacolins in red yeast riceThe short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular riskVariability in strength of red yeast rice supplements purchased from mainstream retailersFood supplements with red yeast rice: More regulations are neededRot fermentierter Reis (Hongqu) — über die Aktualität eines traditionellen chinesischen ArzneimittelsAdverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance systemAtteintes musculaires et levure de riz rouge : analyse des données de la base nationale de pharmacovigilance et revue de la littératureS.A.M. and Breast Cancer—Focus on Statins, Red Yeast Rice, Sterols, and Other Integrative Cholesterol Medicines: The Real "Natural" OptionsCan red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: a double blind, placebo controlled randomized trialDietary Supplements for Cholesterol ManagementDetermination of statins by gas chromatography – EI/MRM – Tandem mass spectrometry: Fermentation of pine samples with Pleurotus ostreatusToxic MyopathiesRed yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trialProximal myopathy: diagnostic approach and initial managementLovastatin Content of Commercially Available Red Yeast Rice SupplementsInteraction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of LovastatinStatin Clinical Trial (REALITY) for Prostate Cancer: an Over 15-Year Wait is Finally Over Thanks to a Dietary SupplementThe Role of Red Yeast Rice for the PhysicianHyperlipidemiaAn alternative treatment of hyperlipidemia with red yeast rice: a case reportRole of dietary supplements in lowering low-density lipoprotein cholesterol: A reviewHealth Benefits and Clinical Impact of Major Nutrient, Red Yeast Rice: A ReviewLipid-Lowering Efficacy of Red Yeast Rice in a Population Intolerant to StatinsRed Yeast Rice for Dyslipidemia in Statin-Intolerant PatientsAnna L. Kolpakchi, MD, Ikedieze I. Chukwu, MD, and Maria T. Vlachaki, MD, MBARed Yeast Rice for Dyslipidemia in Statin-Intolerant PatientsDavid G. Le Couteur, MDAgents and mechanisms of toxic myopathyRed Yeast Rice Increases Excretion of Bile Acids in HamstersRed Yeast Rice for Dyslipidemia in Statin-Intolerant Patients A Randomized TrialDavid J. Becker, MD, Ram Y. Gordon, MD, Steven C. Halbert, MD, Benjamin French, PhD, Patti B. Morris, RD, and Daniel J. Rader, MDSymptomatic Hepatitis Associated with the Use of Herbal Red Yeast RiceHarry Roselle, MD, Andrew Ekatan, MD, Jausheng Tzeng, MD, Mark Sapienza, MD, and Jeffrey Kocher, MDA case report of myopathy from consumption of red yeast riceOne-Month Therapy with Simvastatin Restores Endothelial Function in Hypercholesterolemic Children and Adolescents 19 September 2006Volume 145, Issue 6Page: 474-475KeywordsCreatine kinaseExerciseHyperlipidemiaMyalgiaResearch laboratoriesThoraxThyroidThyroid-stimulating hormoneVital signsWeight loss ePublished: 19 September 2006 Issue Published: 19 September 2006 Copyright & PermissionsCopyright © 2006 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Paul S. Mueller (2006) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: